Related Experiment Videos
Control of bleeding during dermabrasion
The Journal of Dermatologic Surgery and Oncology
|June 1, 1980
Summary
Adrenosem salicylate effectively controlled capillary bleeding during dermabrasion procedures in a study. This medication proved beneficial for reducing oozing without causing adverse effects in patients undergoing skin resurfacing.
Area of Science:
- Dermatology
- Surgical Hemostasis
Background:
- Dermabrasion procedures can lead to significant capillary oozing.
- Controlling intraoperative bleeding is crucial for successful surgical outcomes.
Purpose of the Study:
- To evaluate the efficacy of Adrenosem salicylate in managing capillary oozing during dermabrasion.
- To assess the safety profile of Adrenosem salicylate in this context.
Main Methods:
- A double-blind study was conducted involving ten patients undergoing dermabrasion.
- Patients received Adrenosem salicylate to assess its impact on capillary oozing.
Main Results:
- Adrenosem salicylate significantly reduced capillary oozing during dermabrasion.
- The medication was well-tolerated, with no adverse effects observed in the study participants.
Conclusions:
- Adrenosem salicylate is an effective agent for controlling capillary oozing in dermabrasion.
- The use of Adrenosem salicylate appears safe for patients undergoing this dermatological procedure.